|
"liu yi nan"的相關文件
顯示項目 1-10 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-11-29T05:59:19Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
CHING-YAO YANG; Liao, Wei-Yu; Ho, Chao-Chi; Chen, Kuan-Yu; Tsai, Tzu-Hsiu; Hsu, Chia-Lin; Liu, Yi-Nan; Su, Kang-Yi; Chang, Yih-Leong; Wu, Chen-Tu; Liao, Bin-Chi; Hsu, Chia-Chi; Hsu, Wei-Hsun; LEE JIH-HSIANG; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen |
| 臺大學術典藏 |
2021-11-29T01:54:46Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang, Tzu-Hua; Tsai, Meng-Feng; Gow, Chien-Hung; SHANG-GIN WU; Liu, Yi-Nan; Chang, Yih-Leong; Yu, Sung-Liang; Tsai, Hsing-Chen; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; Yang, Pan-Chyr; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-08-21T23:59:49Z |
Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma
|
Gow, Chien Hung; MIN-SHU HSIEH; Liu, Yi Nan; Lee, Yi Hsuan; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-05-05T05:43:46Z |
miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway
|
Liu, Yi-Nan; Tsai, Meng-Feng; Wu, Shang-Gin; Chang, Tzu-Hua; TZU-HSIU TSAI; Gow, Chien-Hung; Wang, Hsin-Yi; Shih, Jin-Yuan |
| 臺大學術典藏 |
2021-05-02T02:58:15Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; Hsu, Chia-Lang; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; Shih, Jin-Yuan |
| 臺大學術典藏 |
2020-05-20T05:33:08Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
JIN-YUAN SHIH;YEN-TING LIN;Tsai, Meng-Feng;Chang, Tzu-Hua;HSU, CHIA-LANG;Wu, Shang-Gin;Liu, Yi-Nan;Wang, Hsin-Yi; Wang, Hsin-Yi; Liu, Yi-Nan; Wu, Shang-Gin; HSU, CHIA-LANG; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-11-08T02:45:52Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
JIN-YUAN SHIH;PAN-CHYR YANG;Kuo, Po-Yen;Chen, Yen-Wei;Lin, Shih-Wen;HSING-CHEN TSAI;SUNG-LIANG YU;YIH-LEONG CHANG;Liu, Yi-Nan;Wu, Shang-Gin;Gow, Chien-Hung;Tsai, Meng-Feng;Chang, Tzu-Hua; Chang, Tzu-Hua; Tsai, Meng-Feng; Gow, Chien-Hung; Wu, Shang-Gin; Liu, Yi-Nan; YIH-LEONG CHANG; SUNG-LIANG YU; HSING-CHEN TSAI; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-10-23T13:07:22Z |
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
|
JIN-YUAN SHIH;Lin, Yen Ting;Liu, Yi Nan; Liu, Yi Nan; Lin, Yen Ting; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-09-09T00:55:35Z |
Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas
|
Gow, Chien Hung;JIN-YUAN SHIH;Liu, Yi Nan;Lin, Yen Ting;MIN-SHU HSIEH; MIN-SHU HSIEH; Lin, Yen Ting; Liu, Yi Nan; JIN-YUAN SHIH; Gow, Chien Hung |
| 臺大學術典藏 |
2019-03-04T07:58:39Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Tsai, Meng Feng;Tsai, Tzu Hsiu;Luo, Sheng Ching;Chang, Shih Han;Li, Huei Ying;Liu, Yi-Nan;Gow, Chien Hung;JIN-YUAN SHIH;PEI-LUNG CHEN;MIN-SHU HSIEH; Gow, Chien Hung; Liu, Yi-Nan; Li, Huei Ying; MIN-SHU HSIEH; Chang, Shih Han; Luo, Sheng Ching; Tsai, Tzu Hsiu; PEI-LUNG CHEN; Tsai, Meng Feng; JIN-YUAN SHIH |
顯示項目 1-10 / 33 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
